The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms
- 26 September 2023
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 104 (6) , 1206-1218
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasmsLeukemia Research, 2014
- JAK2V 617 F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasmsProceedings of the National Academy of Sciences, 2014
- Correlations between Janus Kinase 2 V617F Allele Burdens and Clinicohematologic Parameters in Myeloproliferative NeoplasmsAnnals of Laboratory Medicine, 2012
- Myeloproliferative neoplasms cause glomerulopathyKidney International, 2011
- The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndromeBlood, 2009
- Renal vascular sclerosis is associated with inherited thrombophiliasKidney International, 2006
- Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: The Hisayama StudyKidney International, 2003
- Renal thrombotic microangiopathy induced by interferon‐αNephrology Dialysis Transplantation, 2001
- Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disordersAmerican Journal of Kidney Diseases, 1999
- Cardiovascular Risk Factors and Hyalinization of Renal Arterioles at AutopsyArteriosclerosis, Thrombosis, and Vascular Biology, 1997